Lierman syndrome is a rare genetic disorder characterized by a complex of congenital developmental anomalies, including cardiovascular defects, skeletal developmental disorders, and specific facial features. The clinical picture of the disease manifests itself as a combination of various dysmorphic features, such as hypertelorism (increased distance between the eyes), low-set ears, chest deformity, and multiple congenital heart defects. The first descriptions of this syndrome appeared in the medical literature in the second half of the 20th century, but questions still remain regarding the exact mechanisms of pathogenesis and optimal approaches to treatment.
History of the disease and interesting historical facts
The first description of Lierman syndrome was presented in 1968 by a group of researchers led by Dr. Robert Leary and Dr. Donald Mann, whose names formed the basis for the name of the disease. In their work, they described in detail the clinical case of a patient with a unique combination of congenital anomalies. Interestingly, this condition was initially mistakenly classified as a variant of DiGeorge syndrome, but subsequent research made it possible to isolate it as a separate nosological entity. “This revolutionary discovery helped to understand the true nature of the disease,” noted Professor of Medical Genetics Jonathan Smith in his 1985 review.
Epidemiology (statistics of disease occurrence)
According to modern epidemiological studies, the incidence of Liermann syndrome is approximately 1 in 200,000 live births. The disease does not have a pronounced gender predisposition, although some studies indicate a slightly higher prevalence among males (ratio 1.2:1). The table below presents data on the prevalence of the disease in different regions of the world:
- North America: 1:220,000
- Europe: 1:230,000
- Asia: 1:250,000
- Africa: 1:270,000
Genetic predisposition to the disease (involved genes and mutations)
Molecular genetic studies have linked Lierman syndrome to mutations in the TBX1 gene, located on the long arm of chromosome 22 (22q11.2). This gene plays a key role in embryonic development, regulating the formation of the cardiovascular system and structures of the head and neck. A feature of the mutations is their spontaneous nature in most cases, although familial cases have also been documented. The main types of mutations include:
- Nonsense mutations
- Deletions of genetic material
- Missense mutations
- Regulatory mutations
Risk factors for the development of this disease
Risk factors for the development of Lierman syndrome include various effects on the body of a pregnant woman during critical periods of embryogenesis. The most significant are the following factors:
- Ionizing radiation in the first trimester of pregnancy
- Taking certain medications (retinoids, antiepileptic drugs)
- Chronic infectious diseases of the mother
- Severe toxicosis of pregnancy
- Living in ecologically disadvantaged areas
Diagnosis of this disease
The diagnostic process for suspected Liermann syndrome includes a comprehensive examination of the patient. The main diagnostic criteria are:
- Clinical signs: characteristic facial dysmorphia, congenital heart defects, chest deformities
- Laboratory tests: cytogenetic analysis, FISH diagnostics of chromosome 22
- Radiological methods: Ultrasound of the heart, chest x-ray, MRI of the brain
- Differential diagnosis: DiGeorge syndrome, Williams syndrome, Sprengel syndrome
Treatment
The therapeutic strategy for Lierman syndrome requires a multidisciplinary approach and includes the following areas:
- General treatment: correction of vital functions of the body, prevention of complications
- Pharmacological therapy: cardiac glycosides, diuretics, antiarrhythmic drugs
- Surgical treatment: correction of congenital heart defects, reconstructive surgery on the face
- Auxiliary methods: physiotherapy, psychological and pedagogical correction
List of drugs used to treat this disease
The main groups of drugs used in the treatment of Lierman syndrome:
- Antiarrhythmics (Amiodarone, Procainamide)
- Beta-blockers (Metoprolol, Bisoprolol)
- ACE inhibitors (Lisinopril, Enalapril)
- Diuretics (Furosemide, Spironolactone)
- Anticoagulants (Warfarin, Rivaroxaban)
Disease monitoring (control stages, prognosis, complications)
Dynamic monitoring of patients with Lierman syndrome includes regular examinations by specialists: cardiologist, geneticist, endocrinologist. Monitoring is carried out according to the following schedule:
- Monthly examination during the first year of life
- Every 3 months up to 3 years
- Twice a year until age 18
- Annually in adulthood
The prognosis depends on the severity of congenital heart defects and the effectiveness of their correction. The main complications are heart failure, infective endocarditis, and delayed psychomotor development.
Age-related features of the disease (how it progresses in different age groups)
Clinical manifestations of Liermann syndrome are age-specific:
- Newborn: cardiovascular disorders and respiratory disorders predominate
- Childhood: dysmorphic features become noticeable, developmental delay
- Adolescence: emphasis on psychological adaptation, problems with peers
- Adulthood: chronic cardiovascular pathology, metabolic disorders
Questions and Answers
- How often should a cardiac examination be performed? Annual echocardiography is recommended with additional monitoring if symptoms of decompensation appear.
- Is a complete cure possible? A complete cure is impossible, but timely correction can significantly improve the quality of life.
- How does the disease affect intellectual development? In 60% cases, mild to moderate mental retardation is observed.
Advice from Dr. Oleg Korzhikov
As an experienced specialist in the field of genetic pathology, I often encounter questions from parents about Lierman syndrome. I will answer the most popular of them:
- When should rehabilitation measures be started? Early initiation of rehabilitation (from the first months of life) significantly improves the prognosis.
- How to prepare for surgery? It is necessary to undergo a full examination, follow all doctor's recommendations and eat properly.
- What to do if a disease is detected during pregnancy? It is important to contact a specialized center for additional diagnostics and genetic consultation.
